Amouyal Philippe's Form 4 filing
Lexicon Pharmaceuticals, Inc.LXRX · filed Nov 14, 2023
- Accession no.
- 0001127602-23-027360
- Filed
- Nov 14, 2023
- Trade date
- Nov 13, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $202.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Amouyal PhilippeCIK 0001376854 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Common Stock | PPurchaseAcquired | +200,000 | $1.01F1 | +$202,000 | 240,332 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $0.9858 to $1.0400 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Amouyal hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
Referenced by the price of 1 transaction in Table I.